Tandem Diabetes Care (TNDM) Change in Accured Expenses (2013 - 2026)

Tandem Diabetes Care's Change in Accured Expenses history runs 14 years deep, the most recent figure standing at -$14.7 million for Q1 2026.

• Quarterly Change in Accured Expenses fell 7.55% year-over-year to -$14.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.7 million (down 119.3% YoY) and the FY2025 annual result came in at -$664000.0, down 103.18% from the prior year.
• Change in Accured Expenses was -$14.7 million for Q1 2026 at Tandem Diabetes Care, down from -$861000.0 in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $15.8 million in Q3 2024 and bottomed at -$40.9 million in Q4 2022.
• A 5-year average of -$287058.8 and a median of $1.1 million in 2025 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2024 — Change in Accured Expenses soared 946.05% — and 2025, when it tumbled 728.78%.
• Tandem Diabetes Care's Change in Accured Expenses stood at -$40.9 million in 2022, then soared by 117.38% to $7.1 million in 2023, then dropped by 21.83% to $5.6 million in 2024, then tumbled by 115.49% to -$861000.0 in 2025, then sank by 1612.31% to -$14.7 million in 2026.
• Business Quant data shows TNDM's Change in Accured Expenses at -$14.7 million in Q1 2026, -$861000.0 in Q4 2025, and $12.8 million in Q3 2025.